Discover how Agilent LC/MS solutions can accurately detect, identify and quantify nitrosamines in APIs and drug products

Recently, the U.S. Food and Drug Administration found nitrosamines impurities in several ranitidine and sartan-based drugs, resulting in widespread recall of these drugs.

Several LC/MS based approaches have since been published to provide options for regulators and industries to detect nitrosamine impurities in ranitidine and sartan drug substances and drug products.